These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35860792)

  • 1. Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease.
    Alden EC; Lundt ES; Twohy EL; Christianson TJ; Kremers WK; Machulda MM; Jack CR; Knopman DS; Mielke MM; Petersen RC; Stricker NH
    Alzheimers Dement (Amst); 2022; 14(1):e12325. PubMed ID: 35860792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mayo Normative Studies: Amyloid and Neurodegeneration Negative Normative Data for the Auditory Verbal Learning Test and Sex-Specific Sensitivity to Mild Cognitive Impairment/Dementia.
    Stricker NH; Christianson TJ; Pudumjee SB; Polsinelli AJ; Lundt ES; Frank RD; Kremers WK; Machulda MM; Fields JA; Jack CR; Knopman DS; Graff-Radford J; Vemuri P; Mielke MM; Petersen RC
    J Alzheimers Dis; 2024; 100(3):879-897. PubMed ID: 38995784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer's Disease and Incident Mild Cognitive Impairment: Implications for Defining Subtle Objective Cognitive Impairment.
    Stricker NH; Lundt ES; Albertson SM; Machulda MM; Pudumjee SB; Kremers WK; Jack CR; Knopman DS; Petersen RC; Mielke MM
    J Alzheimers Dis; 2020; 76(1):261-274. PubMed ID: 32538841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mayo Normative Studies: Regression-Based Normative Data for the Auditory Verbal Learning Test for Ages 30-91 Years and the Importance of Adjusting for Sex.
    Stricker NH; Christianson TJ; Lundt ES; Alden EC; Machulda MM; Fields JA; Kremers WK; Jack CR; Knopman DS; Mielke MM; Petersen RC
    J Int Neuropsychol Soc; 2021 Mar; 27(3):211-226. PubMed ID: 32815494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stricker Learning Span criterion validity: a remote self-administered multi-device compatible digital word list memory measure shows similar ability to differentiate amyloid and tau PET-defined biomarker groups as in-person Auditory Verbal Learning Test.
    Stricker NH; Stricker JL; Frank RD; Fan WZ; Christianson TJ; Patel JS; Karstens AJ; Kremers WK; Machulda MM; Fields JA; Graff-Radford J; Jack CR; Knopman DS; Mielke MM; Petersen RC
    J Int Neuropsychol Soc; 2024 Feb; 30(2):138-151. PubMed ID: 37385974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer's Disease Based on Cogstate One Card Learning Accuracy Performance.
    Pudumjee SB; Lundt ES; Albertson SM; Machulda MM; Kremers WK; Jack CR; Knopman DS; Petersen RC; Mielke MM; Stricker NH
    J Alzheimers Dis; 2021; 83(2):861-877. PubMed ID: 34366338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rey Auditory Verbal Learning Test: Cross-validation of Mayo Normative Studies (MNS) demographically corrected norms with confidence interval estimates.
    Loring DW; Saurman JL; John SE; Bowden SC; Lah JJ; Goldstein FC
    J Int Neuropsychol Soc; 2023 May; 29(4):397-405. PubMed ID: 35481552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal normative standards for cognitive tests and composites using harmonized data from two Wisconsin AD-risk-enriched cohorts.
    Jonaitis EM; Hermann BP; Mueller KD; Clark LR; Du L; Betthauser TJ; Cody K; Gleason CE; Christian BT; Asthana S; Chappell RJ; Chin NA; Johnson SC; Langhough RE
    Alzheimers Dement; 2024 May; 20(5):3305-3321. PubMed ID: 38539269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and education adjusted normative data and discriminative validity for Rey's Auditory Verbal Learning Test in the elderly Greek population.
    Messinis L; Nasios G; Mougias A; Politis A; Zampakis P; Tsiamaki E; Malefaki S; Gourzis P; Papathanasopoulos P
    J Clin Exp Neuropsychol; 2016; 38(1):23-39. PubMed ID: 26588427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional associations of CSF tau levels with Rey's AVLT: A recency ratio study.
    Bruno D; Jauregi Zinkunegi A; Pomara N; Zetterberg H; Blennow K; Koscik RL; Carlsson C; Bendlin B; Okonkwo O; Hermann BP; Johnson SC; Mueller KD
    Neuropsychology; 2023 Sep; 37(6):628-635. PubMed ID: 35604714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data.
    Bos I; Vos SJB; Jansen WJ; Vandenberghe R; Gabel S; Estanga A; Ecay-Torres M; Tomassen J; den Braber A; Lleó A; Sala I; Wallin A; Kettunen P; Molinuevo JL; Rami L; Chetelat G; de la Sayette V; Tsolaki M; Freund-Levi Y; Johannsen P; ; Novak GP; Ramakers I; Verhey FR; Visser PJ
    Front Aging Neurosci; 2018; 10():193. PubMed ID: 29988624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference Data for Attentional, Executive, Linguistic, and Visual Processing Tests Obtained from Cognitively Healthy Individuals with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    López-Martos D; Brugulat-Serrat A; Cañas-Martínez A; Canals-Gispert L; Marne P; Gramunt N; Suárez-Calvet M; Milà-Alomà M; Minguillon C; Fauria K; Zetterberg H; Blennow K; Gispert JD; Molinuevo JL; Grau-Rivera O; Sánchez-Benavides G;
    J Alzheimers Dis; 2023; 95(1):237-249. PubMed ID: 37483000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medial temporal tau predicts memory decline in cognitively unimpaired elderly.
    Kwan ATH; Arfaie S; Therriault J; Azizi Z; Lussier FZ; Tissot C; Chamoun M; Bezgin G; Servaes S; Stevenon J; Rahmouni N; Pallen V; Gauthier S; Rosa-Neto P
    Brain Commun; 2023; 5(1):fcac325. PubMed ID: 36627889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of a positive tau PET scan with a negative amyloid PET scan.
    Robinson CG; Lee J; Min PH; Przybelski SA; Josephs KA; Jones DT; Graff-Radford J; Boeve BF; Knopman DS; Jack CR; Petersen RC; Machulda MM; Fields JA; Lowe VJ
    Alzheimers Dement; 2024 Mar; 20(3):1923-1932. PubMed ID: 38159060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mayo-PACC: A parsimonious preclinical Alzheimer's disease cognitive composite comprised of public-domain measures to facilitate clinical translation.
    Stricker NH; Twohy EL; Albertson SM; Karstens AJ; Kremers WK; Machulda MM; Fields JA; Jack CR; Knopman DS; Mielke MM; Petersen RC
    Alzheimers Dement; 2023 Jun; 19(6):2575-2584. PubMed ID: 36565459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.
    Sperling RA; Donohue MC; Rissman RA; Johnson KA; Rentz DM; Grill JD; Heidebrink JL; Jenkins C; Jimenez-Maggiora G; Langford O; Liu A; Raman R; Yaari R; Holdridge KC; Sims JR; Aisen PS
    J Prev Alzheimers Dis; 2024; 11(4):802-813. PubMed ID: 39044488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying the minimum criteria for diagnosing amnestic MCI to improve prediction of brain atrophy and progression to Alzheimer's disease.
    Vuoksimaa E; McEvoy LK; Holland D; Franz CE; Kremen WS;
    Brain Imaging Behav; 2020 Jun; 14(3):787-796. PubMed ID: 30511118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese version of the auditory verbal learning test: normative study and clinical applications in Chinese-speaking population in Shijiazhuang city.
    Dong FM; Wang W; Guo SZ; Shao K; Song YX; Han N; Jia YL; Feng RF; Wang JH
    Acta Neurol Belg; 2023 Jun; 123(3):873-883. PubMed ID: 35908017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.